These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16001393)

  • 1. Degradation and drug release of phosphate glass/polycaprolactone biological composites for hard-tissue regeneration.
    Kim HW; Lee EJ; Jun IK; Kim HE; Knowles JC
    J Biomed Mater Res B Appl Biomater; 2005 Oct; 75(1):34-41. PubMed ID: 16001393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New generation poly(ε-caprolactone)/gel-derived bioactive glass composites for bone tissue engineering: Part I. Material properties.
    Dziadek M; Menaszek E; Zagrajczuk B; Pawlik J; Cholewa-Kowalska K
    Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():9-21. PubMed ID: 26249560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation properties and ion release characteristics of Resilon and phosphate glass/polycaprolactone composites.
    Borbely P; Gulabivala K; Knowles JC
    Int Endod J; 2008 Dec; 41(12):1093-100. PubMed ID: 19133099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of polycaprolactone composite properties through incorporation of mixed phosphate glass formulations.
    Shah Mohammadi M; Ahmed I; Marelli B; Rudd C; Bureau MN; Nazhat SN
    Acta Biomater; 2010 Aug; 6(8):3157-68. PubMed ID: 20206722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of biphasic calcium phosphates on drug release and biological and mechanical properties of poly(epsilon-caprolactone) composite membranes.
    Kim HW; Knowles JC; Kim HE
    J Biomed Mater Res A; 2004 Sep; 70(3):467-79. PubMed ID: 15293321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glass composition on the degradation properties and ion release characteristics of phosphate glass--polycaprolactone composites.
    Prabhakar RL; Brocchini S; Knowles JC
    Biomaterials; 2005 May; 26(15):2209-18. PubMed ID: 15585222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solvent-dependent properties of electrospun fibrous composites for bone tissue regeneration.
    Patlolla A; Collins G; Arinzeh TL
    Acta Biomater; 2010 Jan; 6(1):90-101. PubMed ID: 19631769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Si and Fe doping on calcium phosphate glass fibre reinforced polycaprolactone bone analogous composites.
    Mohammadi MS; Ahmed I; Muja N; Almeida S; Rudd CD; Bureau MN; Nazhat SN
    Acta Biomater; 2012 Apr; 8(4):1616-26. PubMed ID: 22248526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sol-gel derived nanoscale bioactive glass (NBG) particles reinforced poly(ε-caprolactone) composites for bone tissue engineering.
    Lei B; Shin KH; Noh DY; Jo IH; Koh YH; Kim HE; Kim SE
    Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1102-8. PubMed ID: 23827548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and electrospinning of ε-polycaprolactone-bioactive glass hybrid biomaterials via a sol-gel process.
    Allo BA; Rizkalla AS; Mequanint K
    Langmuir; 2010 Dec; 26(23):18340-8. PubMed ID: 21050002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical, degradation and cytocompatibility properties of magnesium coated phosphate glass fibre reinforced polycaprolactone composites.
    Liu X; Hasan MS; Grant DM; Harper LT; Parsons AJ; Palmer G; Rudd CD; Ahmed I
    J Biomater Appl; 2014 Nov; 29(5):675-87. PubMed ID: 25028389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulatory Effects of Boron Containing Bioactive Glass on Osteogenesis and Angiogenesis of Polycaprolactone: In Vitro Study.
    Xia L; Ma W; Zhou Y; Gui Z; Yao A; Wang D; Takemura A; Uemura M; Lin K; Xu Y
    Biomed Res Int; 2019; 2019():8961409. PubMed ID: 31011582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion release characteristics, precipitate formation and sealing ability of a phosphate glass-polycaprolactone-based composite for use as a root canal obturation material.
    Alani A; Knowles JC; Chrzanowski W; Ng YL; Gulabivala K
    Dent Mater; 2009 Mar; 25(3):400-10. PubMed ID: 19100612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro/in vivo biocompatibility and mechanical properties of bioactive glass nanofiber and poly(epsilon-caprolactone) composite materials.
    Jo JH; Lee EJ; Shin DS; Kim HE; Kim HW; Koh YH; Jang JH
    J Biomed Mater Res B Appl Biomater; 2009 Oct; 91(1):213-20. PubMed ID: 19422050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porous silicon-poly(ε-caprolactone) film composites: evaluation of drug release and degradation behavior.
    Bodiford NK; McInnes SJP; Voelcker NH; Coffer JL
    Biomed Microdevices; 2018 Aug; 20(3):71. PubMed ID: 30097808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication and characterization of poly-(ε)-caprolactone and bioactive glass composites for tissue engineering applications.
    Mohammadkhah A; Marquardt LM; Sakiyama-Elbert SE; Day DE; Harkins AB
    Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():632-639. PubMed ID: 25686992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrospun curcumin loaded poly(ε-caprolactone)/gum tragacanth nanofibers for biomedical application.
    Ranjbar-Mohammadi M; Bahrami SH
    Int J Biol Macromol; 2016 Mar; 84():448-56. PubMed ID: 26706845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and Effects on Dental Pulp Cells of a Polycaprolactone/Submicron Bioactive Glass Composite Scaffold.
    Wang S; Hu Q; Gao X; Dong Y
    J Endod; 2016 Jul; 42(7):1070-5. PubMed ID: 27325456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoconductive and degradable electrospun nonwoven poly(epsilon-caprolactone)/CaO-SiO2 gel composite fabric.
    Seol YJ; Kim KH; Kim IA; Rhee SH
    J Biomed Mater Res A; 2010 Aug; 94(2):649-59. PubMed ID: 20213814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyapatite formation on sol-gel derived poly(ε-caprolactone)/bioactive glass hybrid biomaterials.
    Allo BA; Rizkalla AS; Mequanint K
    ACS Appl Mater Interfaces; 2012 Jun; 4(6):3148-56. PubMed ID: 22625179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.